Seattle Genetics, Inc. is a company in the U.S. stock market and it is a holding in 112 U.S.-traded ETFs. SGEN has around 10.8M shares in the U.S. ETF market. The largest ETF holder of SGEN is the Invesco QQQ Trust (QQQ), with approximately 1.99M shares. Investors may also find of interest that the ETF with the largest allocation to SGEN stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 4.20%. On average, U.S. ETFs allocate 0.64% of SGEN to their portfolios.
Additionally, SGEN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SGEN as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 64.71%.